Philip Morris South Africa (PMSA) has expressed its excitement about the recent announcement from the U.S. Food and Drug Administration (FDA) granting authorisation for the marketing of 20 ZYN nicotine pouch products in the United States. This significant milestone follows an extensive scientific review under the premarket tobacco product application (PMTA) pathway.